Tag: research

A Milestone in the Fight Against MPNs Marks a Moment to Reflect

Ashley Gould, 23andMe's Vice President Corporate Development and Chief Legal Officer We recently topped our goal of enrolling 1,000 people with a group of rare blood disorders known as myeloproliferative neoplasms, or MPNs. As a testament to the passion of the people who’ve enrolled in our MPN Research ...

Read more

Fighting Rare Blood Cancers

Dr. Ross Levine Last year 23andMe launched a Myeloproliferative Neoplasms Research Initiative to study this group of rare blood cancers. We are now very close to reaching our goal of enrolling 1,000 patients and are encouraged by what we’ve already learned. We’re also humbled that another star in the ...

Read more

Participating in Genetic Research

Not all cancers are created equal. Ask anyone with metastatic breast cancer. For the 155,000 women in the United States living with this diagnosis, each day represents a constant fight against a cancer that has spread into other parts of their bodies — most often their bones, liver, lungs or brain. With ...

Read more

A Milestone in Sarcoma Research

Each person who has joined 23andMe’s Sarcoma research community has their own reasons for participating, but they all share the same hopes that we have — to find the causes for sarcoma and new treatments for this rare cancer. Earlier this month, 23andMe took an important step in that direction when we ...

Read more

Leveraging The Direct-to-Patient Research Model in Rheumatoid Arthritis

Janssen Healthcare Innovation, a unit of Janssen Research & Development, LLC, is sponsoring a study in rheumatoid arthritis patients that will be conducted by MediGuard.org (a subsidiary of Quintiles) and 23andMe. The study, called TogetherRA, will enroll approximately 1,000 patients who are currently ...

Read more

CureTogether with 23andMe

23andMe is passionate about making discoveries that will benefit you. We give individuals access to their DNA data while in turn translating information they’ve volunteered into meaningful genetic discoveries. Today we’re announcing the acquisition of CureTogether, Inc. a company that we’ve admired ...

Read more

Fighting Cancer Together

The American Society of Clinical Oncology recently wrapped up its annual meeting, bringing together health care professionals focused on the fight against cancer. The five days were packed with mind-expanding science and encouraging updates on new efforts for research collaboration between doctors, ...

Read more

23andMe to Present Data from Sarcoma Research at Oncology Conference

Starting today cancer researchers will be gathering in Chicago at the meeting of the American Society of Clinical Oncology. Researchers and doctors at the annual meeting — the world’s largest oncology conference — will hear about the most promising drugs being developed to fight cancer. They’ll spend five ...

Read more

23andMe Partnering with Patients

By Meghan Mullins Before joining 23andMe, I worked at a more traditional genetic research lab. Like virtually all research centers, we didn’t return genetic results to our research participants. I occasionally thought about what that meant, that I knew more about an anonymous stranger’s DNA than he or ...

Read more

National Cancer Research Awareness Month

Cancer is not one disease, but many. Even looking specifically at breast cancer or sarcoma, the more researchers study these diseases, the more they understand that there are many different kinds of breast cancer and sarcoma. This has been one of the most challenging aspects of researching cures for ...

Read more

Return to top